The broad goal of the computational core is to support the cell biology, molecular biology, biochemistry, crystallography, and medicinal chemistry components of the program project towards cures for Chagas' disease, malaria, African sleeping sickness, and leishmaniasis. The targets are cysteine proteases in Trypanosoma cruzi, Plasmodium falciparum, Trypanosoma brucei, and Leishmania major, respectively. Bioinformatics, comparative protein structure modeling, and computational docking will contribute to target discovery, lead discovery, and lead optimization. In particular, computing will be applied to the discovery of potential target cysteine proteases, their protein inhibitors, and drug-like compounds.
The specific aims are: (i) to identify all putative papain-like cysteine proteases in the genomes of T. cruzi, P. falciparum, T.brucei, and L. major, (ii) to identify all putative protein inhibitors of the target cysteine proteases; (iii) to suggest small inhibitors that are suitable as lead compounds for drug development against parasite cysteine proteases; (iv) to support the iterative process of lead optimization for a small number of leads against a small number of protease targets, including cruzein, rhodesain, and falcipains 2 and 3. The proposed computations are timely due to the confluence between the availability of the genomic sequences, protein structures, computing capabilities, and advances in methods for comparison of protein sequences, protein structure modeling, and ligand docking.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI035707-12
Application #
7238717
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
12
Fiscal Year
2006
Total Cost
$146,026
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Lee, Gregory M; Balouch, Eaman; Goetz, David H et al. (2012) Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy. Biochemistry 51:10087-98
Doyle, Patricia S; Zhou, Yuan M; Hsieh, Ivy et al. (2011) The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog 7:e1002139
Boyom, Fabrice Fekam; Fokou, Patrick Valere Tsouh; Yamthe, Lauve Rachel Tchokouaha et al. (2011) Potent antiplasmodial extracts from Cameroonian Annonaceae. J Ethnopharmacol 134:717-24
Swenerton, Ryan K; Zhang, Shuyi; Sajid, Mohammed et al. (2011) The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion. J Biol Chem 286:429-40
Robertson, Stephanie A; Renslo, Adam R (2011) Drug discovery for neglected tropical diseases at the Sandler Center. Future Med Chem 3:1279-88
Brak, Katrien; Kerr, Iain D; Barrett, Kimberly T et al. (2010) Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy. J Med Chem 53:1763-73
Guiguemde, W Armand; Shelat, Anang A; Bouck, David et al. (2010) Chemical genetics of Plasmodium falciparum. Nature 465:311-5
Na, Byoung-Kuk; Bae, Young-An; Zo, Young-Gun et al. (2010) Biochemical properties of a novel cysteine protease of Plasmodium vivax, vivapain-4. PLoS Negl Trop Dis 4:e849
Sun, Lingzhi; Shah, Falgun; Helal, Mohamed A et al. (2010) Design, synthesis, and development of novel guaianolide-endoperoxides as potential antimalarial agents. J Med Chem 53:7864-8
Loser, Reik; Gut, Jiri; Rosenthal, Philip J et al. (2010) Antimalarial activity of azadipeptide nitriles. Bioorg Med Chem Lett 20:252-5

Showing the most recent 10 out of 126 publications